Parametric Portfolio Associates’s Metacrine, Inc. Common Stock MTCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-55,753
Closed -$212K 3694
2021
Q2
$212K Sell
55,753
-38,487
-41% -$159K ﹤0.01% 3388
2021
Q1
$584K Buy
94,240
+52,469
+126% +$465K ﹤0.01% 3424
2020
Q4
$328K Buy
41,771
+1,581
+4% +$14.5K ﹤0.01% 3557
2020
Q3
$410K Buy
+40,190
New +$411K ﹤0.01% 3363

Other funds holding MTCR

Parametric Portfolio Associates's MTCR Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Metacrine, Inc. Common Stock (MTCR) in Q3 2021, closing a stake of 55,753 shares — an estimated $212K sold.

Parametric Portfolio Associates first reported a position in MTCR in Q3 2020 and held it in 4 quarters. The position peaked at $584K in Q1 2021. 35 funds tracked by Wall St. Rank hold MTCR as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining Metacrine, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 55,753 Metacrine, Inc. Common Stock shares in Q3 2021, an estimated $212K.
  • Parametric Portfolio Associates first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Parametric Portfolio Associates's Metacrine, Inc. Common Stock position peaked at $584K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.